Tag: DSUR

FDA BIMO Expectations: Inspection Readiness from Day 0

Posted on digi By digi

FDA BIMO Expectations: Inspection Readiness from Day 0 Building Day-0 Inspection Readiness: Meeting FDA BIMO Expectations with Evidence, Control, and Operational Rhythm What “Day-0 inspection readiness” really means—and why it accelerates US programs Define the goal in operational terms “Day-0 inspection readiness” means that if an investigator appeared today, the study’s conduct and records would…

Read More “FDA BIMO Expectations: Inspection Readiness from Day 0” »

US Regulatory Submissions

Clinical Protocol in INDs: Risk, Endpoints & Amendment Strategy

Posted on digi By digi

Clinical Protocol in INDs: Risk, Endpoints & Amendment Strategy Designing the Clinical Protocol for an IND: Risk Controls, Endpoints That Stand Up to Review, and a Smart Amendment Strategy Why the IND protocol is your single most leveraged document—and how to make it decision-ready Anchor to patient protection and decision utility The clinical protocol submitted…

Read More “Clinical Protocol in INDs: Risk, Endpoints & Amendment Strategy” »

US Regulatory Submissions

IND Safety Reporting: What Triggers, Timelines, Forms & Best Practices

Posted on digi By digi

IND Safety Reporting: What Triggers, Timelines, Forms & Best Practices IND Safety Reporting in the US: Triggers, Timelines, Forms, and Proven Practices for Inspection-Ready Programs Why IND safety reporting is mission-critical—and what “good” looks like in practice Regulatory intent: rapid detection, rapid communication, zero ambiguity IND safety reporting is designed to protect participants and preserve…

Read More “IND Safety Reporting: What Triggers, Timelines, Forms & Best Practices” »

US Regulatory Submissions

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)

Posted on digi By digi

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C) From Pre-IND to IND: A US-First FDA Meeting Strategy with Reviewer-Ready Packages and Predictable Outcomes (Type B/C) Outcome-Oriented Game Plan: What “Good” Looks Like from Pre-IND to IND (US-First with EU/UK Mapping) Decisions before documents: frame the meeting around outcomes The most successful sponsors…

Read More “Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)” »

US Regulatory Submissions

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)

Posted on digi By digi

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C) From Pre-IND to IND: A US-First FDA Meeting Strategy with Reviewer-Ready Packages and Avoidable Pitfalls (Type B/C) Outcome-Oriented Game Plan: What “Good” Looks Like from Pre-IND to IND (US-First with EU/UK Mapping) Decisions before documents: frame the meeting around outcomes The most successful sponsors…

Read More “Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)” »

US Regulatory Submissions

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)

Posted on digi By digi

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C) From Pre-IND to IND: A US-First FDA Meeting Strategy with Reviewer-Ready Packages and Avoidable Pitfalls (Type B/C) Outcome-Oriented Game Plan: What “Good” Looks Like from Pre-IND to IND (US-First with EU/UK Mapping) Decisions before documents: frame the meeting around outcomes The most successful sponsors…

Read More “Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)” »

US Regulatory Submissions

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)

Posted on digi By digi

Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C) From Pre-IND to IND: A US-First FDA Meeting Strategy with Reviewer-Ready Packages and Avoidable Pitfalls (Type B/C) Outcome-Oriented Game Plan: What “Good” Looks Like from Pre-IND to IND (US-First with EU/UK Mapping) Decisions before documents: frame the meeting around outcomes The most successful sponsors…

Read More “Pre-IND to IND: FDA Meeting Strategy, Packages & Pitfalls (Type B/C)” »

US Regulatory Submissions